Johanna Amunjela, a Namibian scientist based in the United Kingdom, has identified potential new targets for the treatment of certain types of cancer including brain cancer, breast cancer and gastric cancer.
She will present these exciting findings at the Genes and Cancer conference to be held at the University of Cambridge in the United Kingdom from the 13 to 15 April 2015.
The research that Amunjela carries out at the University of Aberdeen, supervised by Dr Steven Tucker, is among the first in the world to investigate the role that specific proteins called ‘Popeye domain containing protein1, 2 and 3 or Popdc1, 2 and 3’ play in the spread of cancer. Amunjela said: “It is very interesting to find that the effect of these proteins varies according to the type of cancer we looked at. We hope that they can be targeted to improve the treatment of many types cancer.”
Amunjela is pursuing her PhD studies in cancer research at the University of Aberdeen in the United Kingdom. She was previously awarded a JC Petrie Prize by the same university for graduated top of her MSc Clinical Pharmacology class in November 2013. I am immensely grateful to the University of Aberdeen for and my very supportive supervisor Dr Steven Tucker for recognising my potential and believing in my intellectual abilities. I also hugely appreciate the funding from the University of Aberdeen, that enabled us to carry out this research. I am very passionate about cancer research and I feel very blessed to have the opportunity to wake up every day strategizing about how to develop better cancer medicines and then test out my ideas.